JYNEVA W PICKEL
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Pediatrics NEW YORK, NY NPI 1992311567
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Pediatrics NY Takeda Pharmaceuticals U.S.A., Inc. All categories
General Payments — all program years on this page
$471.72
- Category: General Payments
- Program years: PY2021–2022
- Record count: 8
- As of (CMS publication): 2026-01-23
Latest program year (PY2022): $404.22 across 7 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2022) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $404.22 | 7 |
By paying entity
Latest program year (PY2022) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $192.67 | 2 |
| GENZYME CORPORATION | $139.17 | 1 |
| Kaleo, Inc. | $39.31 | 2 |
| GlaxoSmithKline, LLC. | $19.86 | 1 |
| Merck Sharp & Dohme Corporation | $13.21 | 1 |
By program year
Records — PY2022 (7)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 938916107 | GENZYME CORPORATION | $139.17 | 11/07/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 941054477 | kaleo, Inc. | $19.24 | 01/26/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 941054483 | kaleo, Inc. | $20.07 | 02/16/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 944436255 | Merck Sharp & Dohme LLC | $13.21 | 04/14/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 945115119 | GlaxoSmithKline, LLC. | $19.86 | 03/04/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 956139759 | Takeda Pharmaceuticals U.S.A., Inc. | $70.24 | 06/29/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 956139763 | Takeda Pharmaceuticals U.S.A., Inc. | $122.43 | 09/13/2022 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2022_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.